Insider · CIK 0001880979

Jacobsen John R.

Reports to the SEC for 1 company · SOUTH SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001880979

Forms 4 and 5

Insider transactions

41 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2023-08-09	DICE Therapeutics, Inc.Stock Option (right to buy)D Disposition to Issuer	CSO	DDisposition to Issuer	−90K sh	—	—	0
2023-08-09	DICE Therapeutics, Inc.Stock Option (right to buy)D Disposition to Issuer	CSO	DDisposition to Issuer	−154K sh	—	—	0
2023-08-09	DICE Therapeutics, Inc.Restricted Stock UnitsD Disposition to Issuer	CSO	DDisposition to Issuer	−15K sh	—	—	0
2023-08-09	DICE Therapeutics, Inc.D Disposition to Issuer	CSO	DDisposition to Issuer	−147K sh	—	—	0
2023-08-09	DICE Therapeutics, Inc.Stock Option (right to buy)D Disposition to Issuer	CSO	DDisposition to Issuer	−4,367 sh	—	—	0
2023-08-09	DICE Therapeutics, Inc.Stock Option (right to buy)D Disposition to Issuer	CSO	DDisposition to Issuer	−922 sh	—	—	0
2023-08-09	DICE Therapeutics, Inc.Stock Option (right to buy)D Disposition to Issuer	CSO	DDisposition to Issuer	−1,278 sh	—	—	0
2023-08-09	DICE Therapeutics, Inc.Stock Option (right to buy)D Disposition to Issuer	CSO	DDisposition to Issuer	−4,229 sh	—	—	0
2023-08-09	DICE Therapeutics, Inc.Stock Option (right to buy)D Disposition to Issuer	CSO	DDisposition to Issuer	−1,344 sh	—	—	0
2023-08-09	DICE Therapeutics, Inc.Stock Option (right to buy)D Disposition to Issuer	CSO	DDisposition to Issuer	−4,408 sh	—	—	0
2023-08-09	DICE Therapeutics, Inc.Stock Option (right to buy)D Disposition to Issuer	CSO	DDisposition to Issuer	−14.3K sh	—	—	0
2023-08-09	DICE Therapeutics, Inc.Stock Option (right to buy)D Disposition to Issuer	CSO	DDisposition to Issuer	−7,579 sh	—	—	0
2023-08-09	DICE Therapeutics, Inc.Stock Option (right to buy)D Disposition to Issuer	CSO	DDisposition to Issuer	−11.1K sh	—	—	0
2023-08-09	DICE Therapeutics, Inc.Stock Option (right to buy)D Disposition to Issuer	CSO	DDisposition to Issuer	−46.3K sh	—	—	0
2023-06-01	DICE Therapeutics, Inc.S Sale	CSO	SSale	−14.3K sh	$30.31	−$434K	151,940
2023-06-01	DICE Therapeutics, Inc.S Sale	CSO	SSale	−4,443 sh	$31.24	−$139K	147,497
2023-04-18	DICE Therapeutics, Inc.S Sale	CSO	SSale	−16.4K sh	$30.08	−$493K	166,247
2023-03-31	DICE Therapeutics, Inc.S Sale	CSO	SSale	−773 sh	$30.00	−$23.2K	182,639
2023-03-29	DICE Therapeutics, Inc.S Sale	CSO	SSale	−1,094 sh	$30.00	−$32.8K	183,412
2023-03-28	DICE Therapeutics, Inc.S Sale	CSO	SSale	−500 sh	$30.09	−$15K	184,506
2023-01-27	DICE Therapeutics, Inc.Restricted Stock Unit (RSU)A Award	CSO	AAward	+15K sh	—	—	15,000
2023-01-27	DICE Therapeutics, Inc.Stock Option (right to buy)A Award	CSO	AAward	+90K sh	—	—	90,000
2022-04-14	DICE Therapeutics, Inc.Stock Option (right to buy)A Award	CSO	AAward	+154K sh	—	—	154,250
2021-09-14	DICE Therapeutics, Inc.Stock Option (right to buy)A Award	CSO	AAward	+14.3K sh	—	—	14,341
2021-09-14	DICE Therapeutics, Inc.Stock Option (right to buy)A Award	CSO	AAward	+7,579 sh	—	—	7,579
2021-09-14	DICE Therapeutics, Inc.Stock Option (right to buy)A Award	CSO	AAward	+11.1K sh	—	—	11,064
2021-09-14	DICE Therapeutics, Inc.Stock Option (right to buy)A Award	CSO	AAward	+8,520 sh	—	—	8,520
2021-09-14	DICE Therapeutics, Inc.Stock Option (right to buy)A Award	CSO	AAward	+1,250 sh	—	—	1,250
2021-09-14	DICE Therapeutics, Inc.Stock Option (right to buy)A Award	CSO	AAward	+1,525 sh	—	—	1,525
2021-09-14	DICE Therapeutics, Inc.Stock Option (right to buy)A Award	CSO	AAward	+4,075 sh	—	—	4,075
2021-09-14	DICE Therapeutics, Inc.Stock Option (right to buy)A Award	CSO	AAward	+1,250 sh	—	—	1,250
2021-09-14	DICE Therapeutics, Inc.Stock Option (right to buy)A Award	CSO	AAward	+3,750 sh	—	—	3,750
2021-09-14	DICE Therapeutics, Inc.Stock Option (right to buy)A Award	CSO	AAward	+12.2K sh	—	—	12,204
2021-09-14	DICE Therapeutics, Inc.Stock Option (right to buy)A Award	CSO	AAward	+6,250 sh	—	—	6,250
2021-09-14	DICE Therapeutics, Inc.Stock Option (right to buy)A Award	CSO	AAward	+7,500 sh	—	—	7,500
2021-09-14	DICE Therapeutics, Inc.Stock Option (right to buy)A Award	CSO	AAward	+4,408 sh	—	—	4,408
2021-09-14	DICE Therapeutics, Inc.Stock Option (right to buy)A Award	CSO	AAward	+1,344 sh	—	—	1,344
2021-09-14	DICE Therapeutics, Inc.Stock Option (right to buy)A Award	CSO	AAward	+4,229 sh	—	—	4,229
2021-09-14	DICE Therapeutics, Inc.Stock Option (right to buy)A Award	CSO	AAward	+1,278 sh	—	—	1,278
2021-09-14	DICE Therapeutics, Inc.Stock Option (right to buy)A Award	CSO	AAward	+922 sh	—	—	922
2021-09-14	DICE Therapeutics, Inc.Stock Option (right to buy)A Award	CSO	AAward	+4,367 sh	—	—	4,367

Recent filings

Accepted (ET)
Aug 94
Jacobsen John R.0001209191-23-045171
SEC(opens sec.gov)
Jun 24
Jacobsen John R.0001209191-23-034096
SEC(opens sec.gov)
Apr 194
Jacobsen John R.0001209191-23-024918
SEC(opens sec.gov)
Apr 44
Jacobsen John R.0001209191-23-022874
SEC(opens sec.gov)
Mar 304
Jacobsen John R.0001209191-23-021615
SEC(opens sec.gov)

Companies

DICE Therapeutics, Inc.CSO

Address

C/O DICE THERAPEUTICS, INC. 279 E. GRAND AVENUE, SUITE 300, LOBBY B

SOUTH SAN FRANCISCO, CA, 94080